Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2500 participants.

Also called NCT04786769

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,500 participants (planned count) (from the registry)
Sponsor
Hospital de Santa Cruz, Portugal (from the registry)
Registry
  • NCT NCT04786769
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04786769. Randomized; quadruple masking; primary purpose treatment. Start 2022-01 (anticipated); primary completion 2025-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency
Acronym
INERTIA
Condition
Aortic Stenosis
Condition
Iron-deficiency
Intervention (Drug)
Ferric carboxymaltose
Lead sponsor
Hospital de Santa Cruz, Portugal (class: other)

Record details

Record id
cardio:ct-nct04786769
Content hash
d18ca0f35b5be490706abc437846be6cde7614579109d27310d8d4a7722e7c8d